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Background.– Urinary disorders are frequent in multiple sclerosis and can lead
to urological complications and decreased quality of life. Urinary management
guidelines are scarce and targeted to neuro-urology specialists.
Objective.– We present a validated algorithm dedicated to neurologists, PMR and
general practitioners to facilitate first-line evaluation and treatment of urinary
disorders associated with multiple sclerosis: the FLUE-MS algorithm (First-Line
Urological Evaluation in Multiple Sclerosis).
Methods.– This algorithm was derived from literature analysis, evaluated by
an expert panel and validated by means a Delphi method. Urinary Bothersome
Questionnaire in Multiple Sclerosis is also presented. This algorithm is compared
with the other available guidelines.
Discussion.– The FLUE-MS algorithm is designed for neurologists, PMR and
general practitioners, enabling identification of ‘red flags’, timely patient referral
to specialist neuro-urology units, and appropriate first-line therapy.
http://dx.doi.org/10.1016/j.rehab.2014.03.1098
CO20-002-e
Therapeutic management of urinary
disorders in MS
P. Denys a,∗, A. Even a, V. Phé b, E. Chartier-Kastler b
a Service de MPR, Hôpital Raymond-Poincaré, Garches, France
b Service d’Urologie, Hôpital de la Pitié, AP–HP, France
∗Corresponding author.
Keywords: Neurogenic bladder; Multiple sclerosis; Botulinum toxin
Background.– Therapeutic management of urinary disorders in MS is a challenge
for the teams in charge because symptoms, pathophysiology, complications and
therapeutic options may vary with time and deficiencies associated with the
evolution of the disease. Early diagnostic tools, prevention of complications,
symptomatic improvement are the goals of treatment.
Objective.– We review the different medical and surgical options that are val-
idated for the treatment of Urinary disorders in MS. Recent advances such
as botulinum toxin detrusor injections, sacral or tibial neuromodulation are
presented.
Methods.– This lecture derived from an extensive review of the literature.
Discussion.– Therapeutic management of urinary disorders is important in term
of quality of life improvement. Access to medical treatment is actually limited
despite numerous innovative treatments at each stage of the disease. Early diag-
nostic, appropriate follow-up and multidisciplinary approach guaranty the best
management.
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Background.– Sexual dysfunction (SD) is highly prevalent in patients with mul-
tiple sclerosis (MS), affecting 50% to 80% of both male and female patients,
and has a major impact on quality of life. Men present with erectile and ejac-
ulatory dysfunctions (retarded, premature or anejaculation), and partial loss of
libido. This leads to decreased frequency of intercourse, difficulty with achieving
orgasm, and dissatisfaction with sexual performance.
Results.– Women commonly report reduced genital sensation, reduced vagi-
nal lubrication, difficulty with arousal, and difficulty reaching orgasm. In both
sexes, fatigue, spasticity, hand tremors, neuropathic pain, and anxiety about
incontinence contribute to SD. Psychosocial and cultural issues also need eval-
uating, and include depression, performance anxiety, changes in family roles,
lowered self-esteem, loss of confidence. In men, treatments are similar to that of
other neurological diseases: erectile dysfunction can be treated with phosphodie-
sterase inhibitors and intracavernosus injections, though with limited efficacy.
Ejaculatory dysfunction is managed through penile vibratory stimulation and
midodrine. In women, vaginal dryness can be treated with adequate amount of
water-based lubricants. Sex therapy has a prominent role.
Discussion.– A comprehensive assessment of all theses aspects must be taken
into account. The treatment of SD requires multidisciplinary teamwork and
cooperation among specialists, individual patients and partners.
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